Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Short-Term Debt issuances (2022 - 2025)

Cryo Cell International (CCEL) has disclosed Short-Term Debt issuances for 4 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-Term Debt issuances fell 0.99% to $2.0 million in Q4 2025 year-over-year; TTM through Nov 2025 was $8.8 million, a 68.58% increase, with the full-year FY2025 number at $8.8 million, up 68.58% from a year prior.
  • Short-Term Debt issuances was $2.0 million for Q4 2025 at Cryo Cell International, down from $4.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $7.7 million in Q4 2022 to a low of $950000.0 in Q3 2023.
  • A 4-year average of $2.8 million and a median of $2.1 million in 2024 define the central range for Short-Term Debt issuances.
  • Biggest YoY gain for Short-Term Debt issuances was 194.74% in 2025; the steepest drop was 0.99% in 2025.
  • Cryo Cell International's Short-Term Debt issuances stood at $7.7 million in 2022, then plummeted by 87.62% to $950000.0 in 2023, then skyrocketed by 112.63% to $2.0 million in 2024, then fell by 0.99% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Short-Term Debt issuances are $2.0 million (Q4 2025), $4.0 million (Q2 2025), and $2.8 million (Q1 2025).